|
State of Florida
Department of Health, Bureau of Epidemiology
EPI UPDATE
May 27, 1999
Richard S. Hopkins, M.D., M.S.P.H., Bureau Chief, State Epidemiologist
Don Ward, Surveillance Section Administrator, Epi Update Managing Editor
Natalie E. Tackett, Epi Update Editor
Bureau of Epidemiology Frequent Contributors:
Steven Wiersma, M.D., M.P.H., Deputy State Epidemiologist |
William J. Bigler, Ph.D., M.S. Senior Epidemiologist |
Jodi Baldy, M.P.H., Biological Scientist IV |
Ursula E. Bauer, Ph.D.,
Chronic Disease Epidemiologist |
John Werth, M.A.
Bureau Education Coordinator |
Lisa Conti, D.V.M., M.P.H., State Public Health Veterinarian |
| |
Regional
Epidemiologists |
Dolly
Katz, Ph.D., M.P.H.,
SE Florida |
Roger Sanderson, R.N., M.A.,
SW Florida |
Carina
Blackmore, M.S. Vet. Med., Ph.D., NE Florida |
Zuber Mulla, M.S.P.H.,
Central Florida |
Gérard
Krause, M.D., D.T.M.H.,
NW Florida |
Please print out this material and share with epidemiology staff, county
health department directors, administrators, medical directors, nursing directors,
environmental health directors and others with an interest in information of this type.
Thank you.
The Bureau of Epidemiology is available 24 hours a day, 7
days a week for consultation at our main number (850/245-4401) PLEASE NOTE:
Consultation after 5 p.m. & on weekends is intended for emergencies.
Epi Update has a home on the World Wide Web at ---
http://www.doh.state.fl.us
The Florida Clean Indoor Air Act regulates smoking in indoor public
places.
To file a complaint call 1-800-337-3742
In this issue:
1. Congratulations to Jeret Madei
2. Enhanced Meningococcal Surveillance in U.S. College Students
3. Foodborne Pathogen Analysis Conference
4. Influenza Summary - Week 19 (Week Ending May 15, 1999)
5. Editors' Corner
6. Weekly Disease Table - Week 20
1. Congratulations to Jeret Madei
Richard Hopkins, MD, MSPH, State Epidemiologist and Bureau Chief
Jeret Madei, the Bureau of Epidemiology webmaster, was recently selected by the
Department of Health Internet and Intranet webmasters to receive the "Charlotte
Award" for web authoring excellence. As a result of Jerets efforts, the
Bureaus web sites were recognized as "having made the most significant
contribution to the DOH web in May 1999." We, in the Bureau of Epidemiology, are
fully aware of the time, interest, dedication and expertise that exemplifies Jeret's work,
on the websites and other projects. We are gratified to see that recognition by others.
Thanks, Jeret.
2. Enhanced Meningococcal Surveillance in U.S. College Students
This information was received on May 24, from Jennifer Capparella, MPH, coordinator of
the CDC project for Enhanced Meningococcal Surveillance in U.S. College Students. The
Florida Department of Health has been an ongoing participant in that project. --Eds.
"I want to thank you for your participation this year in expanded surveillance for
meningococcal disease among college students. I'm pleased to report that all 50 states
participated in this project by determining if a 17-30 year old patient with meningococcal
disease was a college student and filling out a supplemental case report form for all
these cases. Since information on college attendance is not routinely reported, this has
been our first opportunity to gather national information on meningococcal disease in
college students.
"Between September 1998 and May 21, 1999, we identified 83 cases of meningococcal
disease among college students. Cases were reported from 32 states. The median age of
cases was 19 years (range 18-37) and ½ the cases were male. 46% of cases were among
freshmen and 46% lived in dormitories. 6 patients died. 53% of patients had meningitis and
8% had pneumonia. Among the 60 students for which we have serogroup information, 47% were
serogroup C, 27% serogroup B and 19% serogroup Y. Most importantly, we found that the rate
of meningococcal disease among college students between 9/98 and 5/21/99 was 0.6/100,000
and among undergraduates was 0.7/100,000. These rates are actually less than the overall
rate of 1.0/100,000 between 18-23 year olds. However, rates were elevated among subgroups
of college students. Freshmen had a rate of 1.4 and freshmen living in dormitories had a
rate of 3.8/100,000.
"These findings suggest that while overall college students are not at higher risk
for meningococcal disease, subgroups of college students may be at higher risk. As you may
know, we are also collaborating with the American College Health Association in a
case-control study with controls matched to cases by school, sex, and age, and we expect
to complete enrollment by the end of the month. The purpose of the case-control study is
to confirm these findings, as the most likely prevention strategy will target freshmen,
especially those living in dormitories.
"We plan to report the preliminary results from enhanced surveillance at the
American College Health Association Meeting in Philadelphia on June 1. We would appreciate
if you could share the results of this surveillance with others in your department of
health in advance of that meeting.
"Again, I'd like to thank you for your participation this year in this important
project. We plan to continue enhance surveillance for a 2nd year and hope that you will
continue to participate.
3. Foodborne Pathogen Analysis Conference
Submitted by Margaret E. Melton, Biological Administrator, DACS, Division of Food
Safety,
Food and Residue Laboratories.
The 2nd Annual Foodborne Pathogen Analysis Conference sponsored by the
Florida Department of Agriculture and Consumer Services (DACS) will be held July 14-16,
1999 at the Tradewinds on St. Petersburg Beach, Florida. Topics will include a keynote
address by Dr. Michael Brodsky titled "Food Safety An Elusive Goal?" Dr.
Robert Buchanan with FDA and Dr. Larry Beuchat with the University of Georgia will discuss
fresh produce issues and a panel of FDA, DACS, and DOH staff will present the recent
foodborne typhoid outbreak in Florida. Dr. Tim Barrett from CDC will present current
information on PulseNet and FoodNet and Dr. Gerald Crawford of USDA will discuss new more
rapid testing for E.coli 01577.
The Department of Agriculture and Consumer Services is also sponsoring the 36th
Annual Pesticide Residue Workshop on July 11-14, 1999 immediately prior to the Foodborne
Pathogen Analysis Conference. This workshop brings together government, private and
academic scientists from all over the world, in order to exchange information related to
pesticide residue analyses and pesticide regulatory issues.
4. Influenza Summary - Week 19 (Week Ending May 15, 1999)
Carina Blackmore, M.S. Vet. Med., Ph.D., NE Florida
The Flu Season is now over. This Influenza Summary will be our last report until Fall,
1999. Thank you, Dr. Blackmore for providing us with weekly up-to-date information
throughout this season. --Eds.
Both influenza A (H3N2) and B viruses circulated in the United States during the
1998-99 season. Type A predominated (77% of all typed isolates at WHO laboratories).
Influenza activity peaked in the United States overall and in most areas of the country
between early February and mid-March. The maximum number of isolates reported nationally
during any one week occurred the week ending February 20, 1999, when 1,707 of 6,491
specimens tested at the WHO laboratories were positive for influenza.
During week 19, less than 1% of patient visits to U.S. sentinel physicians were due to
influenza-like illness (ILI). Percentages of ILI were 0%-1%, within baseline values of
0%-3% in all nine regions of the country. Influenza morbidity peaked during the first
three weeks of February when 5% of the total patient visits were due to ILI.
State and Territorial Epidemiologists in thirteen states reported sporadic influenza
activity during week 19. No influenza activity was reported from 24 states and 14 states
did not report. In early February, when the peak activity occurred, 42 states reported
either regional or widespread activity.
The percentage of deaths attributed to pneumonia and influenza reported by the 122 U.S.
cities was at the epidemic threshold (6.8%) this week. The epidemic threshold was exceeded
during 19 of 32 weeks during the 1998-1999 season. Pneumonia and influenza mortality
peaked at 8.8% during the week ending March 13, 1999.
Florida: No influenza isolates were reported during week 19 (9-15 May 1999). Since
September 23 and to date, there have been 272 isolates reported; 67 (25 %) of these were
type B, 205 (75%) type A. Of the influenza A isolates, 74 were typed; 68 (30 %) were type
A (H3N2) and 6 (3 %) were type A (H1N1). Isolates have been reported from: Alachua (1),
Brevard (5), Broward (27), Dade (5), Desoto (1), Duval (14), Hillsborough (54), Indian
River (5), Jackson (2), Leon (20), Martin (2) Okaloosa (2), Orange (22), Osceola (1), Palm
Beach (17), Pinellas (12), Polk (7), Sarasota (68), Seminole (2), St. Johns (2) and
Volusia (3) counties.
Of the total patient visits to sentinel physicians during Week 19, 1 % were due to ILI.
This is within the baseline levels of 0-3 %.
Influenza activity peaked in Florida during late January and February (weeks 3-8).
Sentinel physicians in the state reported the highest incidence of disease during week 5
when 4% of their visits were due to ILI. The greatest number of laboratory-confirmed
isolates were reported during week 7 (27 isolates) followed by week 5 (20 isolates).
This is the last report for the 1998-1999 influenza season. Weekly influenza morbidity
updates will resume in October 1999. We greatly appreciate the efforts of everyone (in
medical practices, county health departments and laboratories) who have contributed data
to the influenza surveillance program in Florida this year.
5. Editors' Corner
Please note the following error in last week's article titled, International Travel History of Reported Hepatitis A Cases:
In Table 2, the Number for Asia/South Pacific is 6 (not 5) and for Percent for
Asia/South Pacific it should read 10.9 (not 9.1). The Total Number now adds up to 55
(instead of 54). We apologize for this error.
6. Weekly Disease Table - Week 20
County-Confirmed Cases, Sorted Alphabetically by Disease
NR represents years that the disease lacked status as a reportable condition
DISEASE |
1996 TO DATE |
1997 TO DATE |
1998 TO DATE |
3 YEAR AVERAGE
TO DATE |
1998 TOTAL CASES |
1999 TO DATE |
| Amebiasis |
25 |
16 |
20 |
20.3 |
91 |
14 |
| Anthrax |
0 |
0 |
0 |
0 |
0 |
0 |
| Botulism |
0 |
0 |
0 |
0 |
0 |
0 |
| Brucellosis |
3 |
0 |
1 |
1.3 |
3 |
0 |
| Campylobacteriosis |
355 |
292 |
229 |
292 |
975 |
266 |
| Ciguatera |
7 |
2 |
0 |
3 |
7 |
1 |
| Cryptosporidiosis |
48 |
29 |
33 |
36.7 |
203 |
32 |
| Cyclosporiasis |
0 |
30 |
2 |
10.7 |
7 |
1 |
| Dengue |
0 |
0 |
1 |
0.3 |
5 |
2 |
| Diphtheria |
0 |
0 |
0 |
0 |
0 |
0 |
| E. coli O157:H7 |
7 |
16 |
6 |
9.7 |
56 |
12 |
| E. coli, other (known serotype) |
2 |
2 |
2 |
2 |
12 |
7 |
| Ehrlichiosis, Human |
0 |
0 |
0 |
0 |
1 |
0 |
| Encephalitis, Eastern Equine |
0 |
0 |
0 |
0 |
0 |
0 |
| Encephalitis, St. Louis |
0 |
0 |
0 |
0 |
2 |
0 |
| Encephalitis, other (known organism) |
2 |
6 |
3 |
3.7 |
7 |
2 |
| Encephalitis, post-infectious* |
8 |
3 |
2 |
4.3 |
21 |
3 |
| Giardiasis (acute) |
520 |
485 |
386 |
463.7 |
1635 |
301 |
| Haemophilus influenzae*, invasive |
4 |
7 |
17 |
9.3 |
43 |
24 |
| Hansens Disease (Leprosy) |
0 |
0 |
3 |
1 |
4 |
1 |
| Hantavirus Infection |
0 |
0 |
0 |
0 |
0 |
0 |
| Hemolytic Uremic Syndrome |
0 |
2 |
1 |
1 |
12 |
1 |
| Hemorrhagic Fever |
0 |
0 |
0 |
0 |
0 |
0 |
| Hepatitis A |
158 |
145 |
205 |
169.3 |
539 |
231 |
| Hepatitis B |
156 |
132 |
118 |
135.3 |
464 |
141 |
| Hepatitis Non-A, Non-B |
24 |
27 |
26 |
25.7 |
97 |
3 |
| Hepatitis, unspecified |
1 |
2 |
1 |
1.3 |
24 |
4 |
| Histoplasmosis |
3 |
1 |
5 |
3 |
17 |
0 |
| Kawasaki |
10 |
11 |
22 |
14.3 |
54 |
0 |
| Lead Poisoning |
615 |
472 |
535 |
540.7 |
1815 |
228 |
| Legionellosis |
7 |
7 |
16 |
10 |
48 |
9 |
| Leptospirosis |
0 |
0 |
0 |
0 |
2 |
0 |
| Lyme Disease |
5 |
5 |
10 |
6.7 |
70 |
8 |
| Malaria |
32 |
26 |
22 |
26.7 |
96 |
32 |
| Measles |
1 |
1 |
1 |
1 |
2 |
1 |
| Meningococcal Disease (N. meningitidis) |
91 |
69 |
53 |
71 |
131 |
50 |
| Meningitis, Group B Streptococci |
8 |
5 |
6 |
6.3 |
22 |
6 |
| Meningitis, Haemophilus influenzae |
1 |
4 |
5 |
3.3 |
10 |
9 |
| Meningitis, Streptococcus pneumoniae |
48 |
41 |
43 |
44 |
95 |
53 |
| Meningitis, Listeria monocytogenes |
3 |
0 |
4 |
2.3 |
13 |
5 |
| Meningitis, other bacterial (including unspecified) |
41 |
19 |
19 |
26.3 |
77 |
21 |
| Mercury Poisoning |
5 |
0 |
0 |
1.7 |
4 |
2 |
| Mumps |
3 |
7 |
8 |
6 |
11 |
1 |
| Paralytic Shellfish Poisoning |
0 |
0 |
0 |
0 |
0 |
0 |
| Pertussis |
20 |
31 |
15 |
22 |
39 |
13 |
| Pesticide Poisoning |
0 |
0 |
1 |
0.3 |
1 |
1 |
| Plague |
0 |
0 |
0 |
0 |
0 |
0 |
| Poliomyelitis |
0 |
0 |
0 |
0 |
0 |
0 |
| Psittacosis |
0 |
0 |
0 |
0 |
2 |
0 |
| Rabies, Animal |
81 |
121 |
81 |
94.3 |
215 |
72 |
| Reye Syndrome |
0 |
0 |
1 |
0.3 |
1 |
0 |
| Rocky Mountain Spotted Fever |
0 |
1 |
1 |
0.7 |
2 |
1 |
| Rubella, including congenital |
10 |
0 |
1 |
3.7 |
4 |
0 |
| Salmonellosis |
595 |
532 |
506 |
544.3 |
3037 |
582 |
| Shigellosis |
436 |
358 |
533 |
442.3 |
2340 |
502 |
| Streptococcal Disease, invasive Group A |
0 |
17 |
23 |
13.3 |
58 |
22 |
| Streptococcus pneumoniae, Drug Resistant |
0 |
86 |
207 |
97.7 |
518 |
266 |
| Tetanus |
1 |
0 |
2 |
1 |
3 |
1 |
| Toxic Shock Syndrome |
0 |
0 |
3 |
1 |
4 |
4 |
| Toxoplasmosis |
4 |
3 |
5 |
4 |
15 |
4 |
| Typhoid Fever |
9 |
3 |
8 |
6.7 |
16 |
20 |
| Typhus (Louse & Murine) |
0 |
0 |
0 |
0 |
0 |
0 |
| Vibrio cholerae (serogrp O1) |
0 |
0 |
0 |
0 |
0 |
0 |
| Vibrio cholerae (serogrp Non-O1) |
1 |
3 |
1 |
1.7 |
11 |
3 |
| Vibrio vulnificus |
2 |
3 |
2 |
2.3 |
35 |
3 |
| Vibrio other (including unspecified) |
6 |
10 |
9 |
8.3 |
75 |
12 |
| Yellow Fever |
0 |
0 |
0 |
0 |
0 |
0 |
|